
### [Orphanet:306498](http://www.orpha.net/ORDO/Orphanet_306498)
**Label:** PTEN hamartoma tumor syndrome

**Subclasses:** [Orphanet:2969](http://www.orpha.net/ORDO/Orphanet_2969) (Proteus-like syndrome), [Orphanet:109](http://www.orpha.net/ORDO/Orphanet_109) (Bannayan-Riley-Ruvalcaba syndrome), [Orphanet:744](http://www.orpha.net/ORDO/Orphanet_744) (Proteus syndrome), [Orphanet:201](http://www.orpha.net/ORDO/Orphanet_201) (Cowden syndrome), 

**Corr. equiv. classes:** [Orphanet:201](http://www.orpha.net/ORDO/Orphanet_201), [OMIM:158350](http://purl.obolibrary.org/obo/OMIM_158350), [OMIM:153480](http://purl.obolibrary.org/obo/OMIM_153480), [OMIM:176920](http://purl.obolibrary.org/obo/OMIM_176920), [OMIM:615107](http://purl.obolibrary.org/obo/OMIM_615107), [OMIM:615108](http://purl.obolibrary.org/obo/OMIM_615108), [Orphanet:2969](http://www.orpha.net/ORDO/Orphanet_2969), [OMIM:615106](http://purl.obolibrary.org/obo/OMIM_615106), [OMIM:612359](http://purl.obolibrary.org/obo/OMIM_612359), [OMIM:615109](http://purl.obolibrary.org/obo/OMIM_615109), [OMIM:616858](http://purl.obolibrary.org/obo/OMIM_616858), [Orphanet:109](http://www.orpha.net/ORDO/Orphanet_109), [Orphanet:744](http://www.orpha.net/ORDO/Orphanet_744), 

**Class expressions from DL-Learner:**

- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 69.23%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0100646](http://purl.obolibrary.org/obo/HP_0100646) (Thyroiditis) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0012031](http://purl.obolibrary.org/obo/HP_0012031) (Lipomatous tumor) 65.38%
- [HP:0000545](http://purl.obolibrary.org/obo/HP_0000545) (Myopia) and [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) 65.38%
- [HP:0000539](http://purl.obolibrary.org/obo/HP_0000539) (Abnormality of refraction) and [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) 65.38%
- [HP:0000365](http://purl.obolibrary.org/obo/HP_0000365) (Hearing impairment) and [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) 65.38%
- [HP:0000364](http://purl.obolibrary.org/obo/HP_0000364) (Hearing abnormality) and [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0100835](http://purl.obolibrary.org/obo/HP_0100835) (Benign neoplasm of the central nervous system) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 65.38%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0100031](http://purl.obolibrary.org/obo/HP_0100031) (Neoplasm of the thyroid gland) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 65.38%


